Reportable Segments | Segment Information: In the first quarter of 2018, the PCS product category merged with our former Refining Solutions reportable segment to form a global business focused on catalysts. As a result, our three reportable segments include: (1) Lithium; (2) Bromine Specialties; and (3) Catalysts. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This business structure aligns with the markets and customers we serve through each of the segments. The structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. Results for 2017 have been recast to reflect the change in segments noted above. The “All Other” category includes only the fine chemistry services business that does not fit into any of our core businesses. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses adjusted EBITDA (as defined below) to assess the ongoing performance of the Company’s business segments and to allocate resources. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items in a balanced manner and on a segment basis. These non-recurring or unusual items may include acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended 2018 2017 (In thousands) Net sales: Lithium $ 298,032 $ 216,229 Bromine Specialties 225,639 219,191 Catalysts 260,717 253,558 All Other 37,165 32,419 Corporate 76 666 Total net sales $ 821,629 $ 722,063 Adjusted EBITDA: Lithium $ 131,014 $ 99,852 Bromine Specialties 69,969 68,488 Catalysts 67,830 69,749 All Other 3,862 5,156 Corporate (23,957 ) (31,869 ) Total adjusted EBITDA $ 248,718 $ 211,376 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium Bromine Specialties Catalysts Reportable Segments Total All Other Corporate Consolidated Total Three months ended March 31, 2018 Net income (loss) attributable to Albemarle Corporation $ 108,334 $ 59,536 $ 55,660 $ 223,530 $ 1,760 $ (93,530 ) $ 131,760 Depreciation and amortization 24,065 10,433 12,170 46,668 2,102 1,560 50,330 Acquisition and integration related costs (a) — — — — — 2,201 2,201 Interest and financing expenses — — — — — 13,538 13,538 Income tax expense — — — — — 20,361 20,361 Non-operating pension and OPEB items — — — — — (2,197 ) (2,197 ) Legal accrual (b) — — — — — 17,628 17,628 Other (c) (1,385 ) — — (1,385 ) — 16,482 15,097 Adjusted EBITDA $ 131,014 $ 69,969 $ 67,830 $ 268,813 $ 3,862 $ (23,957 ) $ 248,718 Three months ended March 31, 2017 Net income (loss) attributable to Albemarle Corporation $ 77,614 $ 58,694 $ 56,966 $ 193,274 $ 3,246 $ (145,307 ) $ 51,213 Depreciation and amortization 19,065 9,794 12,783 41,642 1,910 1,518 45,070 Utilization of inventory markup (d) 10,606 — — 10,606 — — 10,606 Restructuring and other, net (e) — — — — — 12,905 12,905 Gain on acquisition (f) (7,433 ) — — (7,433 ) — — (7,433 ) Acquisition and integration related costs (a) — — — — — 14,281 14,281 Interest and financing expenses (g) — — — — — 68,513 68,513 Income tax expense — — — — — 11,971 11,971 Non-operating pension and OPEB items — — — — — (1,063 ) (1,063 ) Other (h) — — — — — 5,313 5,313 Adjusted EBITDA $ 99,852 $ 68,488 $ 69,749 $ 238,089 $ 5,156 $ (31,869 ) $ 211,376 (a) Included amounts for the three-month periods ended March 31, 2018 and 2017 recorded in (1) Cost of goods sold of $1.0 million and $8.9 million , respectively; and (2) Selling, general and administrative expenses of $1.2 million and $5.4 million , respectively, relating to various significant projects, including the Jiangxi Jiangli New Materials Science and Technology Co. Ltd. (“Jiangli New Materials”) acquisition, which contains unusual compensation related costs negotiated specifically as a result of this acquisition that are outside of the Company’s normal compensation arrangements. (b) Included in Other (expenses) income, see Note 10, “Commitments and Contingencies” for additional information. (c) Included amounts for the three months ended March 31, 2018 recorded in: ▪ Cost of goods sold - $1.1 million related to the write-off of fixed assets in our JBC joint venture. ▪ Selling, general and administrative expenses - $1.4 million gain related to a refund from Chilean authorities due to an overpayment made in a prior year. ▪ Other (expenses) income, net - $15.6 million of environmental charges related to a site formerly owned by Albemarle, partially offset by a net gain of $0.2 million related to the the reversal of previously recorded expenses of disposed businesses. (d) In connection with the acquisition of Jiangli New Materials, the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.1 million . The inventory markup was expensed over the estimated remaining selling period. For the three-month period ended March 31, 2017, $10.6 million was included in Cost of goods sold related to the utilization of the inventory markup. (e) During the first quarter of 2017, we initiated actions to reduce costs at several locations, primarily at our Lithium site in Germany. Based on the restructuring plans, we have recorded expenses of $2.9 million in Cost of goods sold, $4.2 million in Selling, general and administrative expenses and $5.8 million in Research and development expenses, primarily related to severance, expected to be incurred. The unpaid balance is recorded in Accrued expenses at March 31, 2018, with the expectation that the majority of these plans will be completed by the end of 2018. (f) Gain recorded in Other (expenses) income, net related to the acquisition of the remaining 50% interest in the Sales de Magnesio Ltda. joint venture in Chile. The calculation of the initial gain recorded during the three months ended March 31, 2017 was based on management’s preliminary estimates and assumptions available at that time. (g) During the first quarter of 2017, we repaid the 3.00% Senior notes in full, €307.0 million of the 1.875% Senior notes and $174.7 million of the 4.50% Senior notes, as well as related tender premiums of $45.2 million . As a result, included in Interest and financing expenses is a loss on early extinguishment of debt of $52.8 million , representing the tender premiums, fees, unamortized discounts and unamortized deferred financing costs from the redemption of these senior notes. (h) Included in Other (expenses) income, net are $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business. |